Additive Effects of N-Acetylcysteine and [R₄W₄] Combination Treatment on Mycobacterium avium

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Mycobacterium avium causes opportunistic infections, particularly in immunocompromised individuals.
• Challenges in treating M. avium include long durations, antibiotic toxicity, and resistance, necessitating novel therapeutic approaches.
• N-acetylcysteine (NAC) exhibits antimycobacterial properties, and antimicrobial peptides like [R4W4] show synergistic effects with antibiotics.

Purpose of the Study:

• To investigate the mechanism of action and efficacy of combined N-acetylcysteine (NAC) and [R4W4] therapy against Mycobacterium avium.
• To evaluate the impact of NAC and [R4W4] on M. avium cell membrane integrity.
• To assess the in vitro and intracellular efficacy of the combination therapy.

Main Methods:

• Membrane depolarization assay to assess effects on M. avium cell membrane integrity.
• Antimycobacterial activity assessed by treating M. avium cultures with varying concentrations of NAC, [R4W4], or their combination.
• Intracellular efficacy evaluated in M. avium-infected THP-1-derived macrophages.

Main Results:

• Both NAC and [R4W4] individually disrupted M. avium membrane potential, with enhanced effects observed upon combination.
• The combination treatment significantly reduced M. avium survival in both planktonic cultures and infected macrophages compared to monotherapy.
• [R4W4] and NAC demonstrated potent antibacterial activity, with the combination exhibiting additive effects and improved bacterial inhibition.

Conclusions:

• The combination of N-acetylcysteine (NAC) and [R4W4] displays additive activity against Mycobacterium avium in vitro.
• Combining antioxidant compounds with antimicrobial peptides presents a potentially effective strategy for managing mycobacterial infections.
• Further research into this combination therapy could lead to improved treatment outcomes for Nontuberculous Mycobacterial infections.